Lumbard Investment Counseling »

Denali Therapeutics shares owned by Lumbard Investment Counseling

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Lumbard Investment Counseling from 13F filings

Historical chart of Lumbard Investment Counseling investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Lumbard Investment Counseling consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Lumbard Investment Counseling

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.8M 95k 19.20

More positions owned by Lumbard Investment Counseling

Petroleo Brasileiro S A Adr (PBR)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
State Street Spdr Bloomberg 1-3 Month T-bill Etf Etf (BIL)
Hudbay Minerals Stock (HBM)
State Street Spdr Portfolio S&p 400 Mid Cap Etf Etf (SPMD)
Goldman Sachs Group Stock (GS)
Invesco S&p 500 Equal Weight Etf Etf (RSP)
Freedom 100 Emerging Markets Etf Etf (FRDM)
Kinder Morgan Inc Del Stock (KMI)
Cisco Sys Stock (CSCO)
Enersys Stock (ENS)
Vanguard International High Dividend Yield Etf Etf (VYMI)
Metlife Stock (MET)
Materion Corp Stock (MTRN)
Kratos Defense & Sec Solutions Stock (KTOS)

View all positions for Lumbard Investment Counseling

Top funds holding Denali Therapeutics

Vanguard Group
BlackRock
Baillie Gifford & Co
T. Rowe Price Investment Management
Temasek Holdings
State Street Corporation
Vanguard Capital Management
Vanguard Portfolio Management
FMR
Ubs Global Asset Management Americas
Goldman Sachs Group
Baker Bros. Advisors
Geode Capital Management
Holocene Advisors
Alliancebernstein

View all funds holding Denali Therapeutics